- Atlas
- Medicine & Health
- Social And Administrative Pharmacy
Social And Administrative Pharmacy
Social and administrative pharmacy is the part of pharmacy that studies medicines as social and economic objects, not only as chemical ones.
13 frameworks, from 1945 to today · Pharmacy · Medicine & Health
- Hospital Pharmacy Administration 1945-Present
- Pharmacy Administration 1950-Present
- Patient adherence 1970-Present
- Social Pharmacy 1970-Present
- Pharmaceutical policy 1977-Present
- Pharmacoeconomics 1980-Present
- Pharmacoepidemiology 1980-Present
- Health Technology Assessment 1985-Present
- Outcomes Research 1985-Present
- Medication Safety 1990-Present
- Pharmaceutical Care 1990-Present
- Access to Medicines 1995-Present
- Deprescribing 2005-Present
Overview
Social and administrative pharmacy is the part of pharmacy that studies medicines as social and economic objects, not only as chemical ones. Where pharmaceutics asks how to make a drug into a usable product and pharmacology asks what it does inside the body, this field asks a different set of questions: Who can afford this medicine? Who decides what gets approved, priced, reimbursed, and prescribed? Why do patients take some medicines and not others? What does a drug cost a health system relative to what it delivers? How do errors happen, and how can they be prevented? Its practitioners are pharmacists, economists, epidemiologists, policy analysts, and health-services researchers. What is at stake is the gap between a medicine that exists and a medicine that actually reaches people, gets taken correctly, and does more good than harm.
The field's name signals its two prongs. The social side borrows from sociology, anthropology, and psychology to study how people and institutions use medicines. The administrative side borrows from economics, management, and law to study how health systems organize, pay for, and regulate them. The two grew up alongside each other and now overlap heavily.
From Apothecary Economics to Health-System Pharmacy
For most of pharmacy's history, the administrative dimension was invisible because it was simply part of the trade. Apothecaries priced their own compounds, competed with physicians who also dispensed, and operated under guild and, later, state regulation. The great pharmacopoeias—the London and Edinburgh pharmacopoeias and their successors—were administrative instruments as much as scientific ones: they standardized what a named preparation should contain, which made prices and expectations comparable.
The turning point was the industrial manufacture of standardized medicines in the late nineteenth and early twentieth centuries, which split compounding from dispensing and pushed the pharmacist's economic role toward retail margin and dispensing fee. Two world wars accelerated state involvement: drug shortages and military procurement forced governments to think about supply, quality, and price. The U.S. Federal Food, Drug, and Cosmetic Act of 1938, which required pre-market proof of safety, and the 1962 thalidomide-driven amendments, which added proof of efficacy, established the modern regulatory apparatus that administrative pharmacy would later study. In the United Kingdom, the establishment of the National Health Service in 1948 made pharmaceutical expenditure a public budget line, and pharmacy contractors negotiated national remuneration—an early, concrete case of pharmaceutical policy analysis in practice.
Hospital pharmacy administration developed as its own discipline in the mid-twentieth century, with formularies, purchasing committees, and pharmacy and therapeutics committees becoming standard. The U.S. hospital pharmacist Donald Francke and the journal he founded, Drug Intelligence (later Drug Intelligence and Clinical Pharmacy), helped articulate hospital pharmacy as a managed system rather than a dispensing counter.
Social Pharmacy and the Behavioural Turn
From the 1960s, a distinctly social strand emerged, initially in the Nordic countries and the United Kingdom. Researchers began applying sociological methods to medicines: studies of prescribing variation, of patient medicine use in the home, and of the pharmacist's professional role. The term social pharmacy crystallized in Nordic and British academic departments in the 1970s and 1980s. The insight that drove it was that prescribing and use are social behaviours—shaped by habits, beliefs, family, advertising, and professional norms—and cannot be understood from the drug's pharmacology alone.
A concrete landmark in this tradition was the study of how patients actually take medicines in their own homes, which repeatedly found that prescribed regimens were adapted, shared, and abandoned in ways no clinical trial captured. This observational strand fed directly into the next major idea.
Pharmaceutical Care and the Reprofessionalization of Pharmacy
In 1990, the American pharmacists Charles Hepler and Linda Strand published a paper arguing that pharmacy's true social mandate was not dispensing products but taking responsibility for the outcomes of drug therapy—a concept they called pharmaceutical care12. A pharmaceutical care practitioner identifies a patient's drug-related needs, prevents and resolves drug therapy problems, and is accountable for results. The idea spread globally and was taken up by the International Pharmaceutical Federation. It reframed the profession's claim on public trust: pharmacists would justify their role by outcomes, not by the act of dispensing. It also created a research agenda—how to measure drug-related problems, how to document pharmacist interventions, how to show that pharmaceutical care improves outcomes—that administrative and social pharmacy methods were needed to answer.
Measuring Medicines: Pharmacoeconomics and Outcomes Research
The 1970s and 1980s brought cost-consciousness to health care, and pharmacy responded by importing economic methods. The question pharmacoeconomics asks is simple to state and hard to answer: given limited money, is this medicine worth what it costs compared with the alternatives? Its core tools are cost-effectiveness analysis (cost per unit of health gained, often per quality-adjusted life-year, a combined measure of length and quality of life), cost-utility analysis, cost-benefit analysis, and budget-impact analysis. The quality-adjusted life-year, or QALY, developed by health economists in the 1970s, became the standard yardstick3.
Pharmacy's contribution was to apply these tools at the level of the drug and the drug class, and to build the data infrastructure they require. The journal PharmacoEconomics, founded in 1992, marked the field's consolidation. Closely related was the rise of outcomes research—studies of what actually happens to patients under real-world conditions, as opposed to the controlled conditions of trials.
Pharmacoepidemiology: Medicines in Populations
Pharmacoepidemiology applies epidemiological methods to drug use in whole populations4. Its founding problem was that pre-marketing trials are too small and too short to detect rare harms or harms that emerge in the old, the young, and the multiply ill. The field's methods—cohort studies, case-control studies, and later the case-crossover and self-controlled designs—were developed to detect signals from routine data. The field was named and given textbook form by Brian Strom in the 1980s. It supplied the evidence base for large withdrawals of drugs found to cause unexpected harm and for the routine systems of adverse-drug-reaction reporting that regulators now maintain.
Medication Adherence: From Compliance to Concordance
Medication adherence research began in earnest in the 1970s, when clinicians noticed that a large share of prescriptions were never filled or not taken as directed. Early work used the language of compliance, framing non-taking as patient failure. A shift occurred in the 1990s toward adherence and then toward concordance—the idea that the prescribing encounter should be a negotiation, with the patient's beliefs and priorities taken seriously. Researchers such as Robert Horne and John Weinman developed instruments to measure patients' beliefs about medicines, showing that concerns about harm and perceived necessity predicted taking behaviour better than demographic factors. The field produced a large catalogue of adherence measures—pill counts, pharmacy refill records, electronic monitoring, self-report—each with known biases, and a sobering conclusion: most adherence interventions produce modest effects.
Medication Safety and Deprescribing
The 1990s turned patient safety into a discipline after studies of hospital harm, and pharmacy developed its own strand. Medication safety research catalogues error types, studies prescribing cascades (where a drug's side effect is treated with another drug), and designs interventions at the system level. The related concept of deprescribing—the planned, supervised withdrawal of medicines that no longer do more good than harm—emerged in geriatric and palliative care in the 2000s, with explicit frameworks and tools for tapering. It is the logical endpoint of the outcomes focus: if a medicine's risks outweigh its benefits, the right clinical act may be to stop it.
Access to Medicines and Pharmaceutical Policy
From the late 1990s, globalization and the HIV/AIDS crisis put access at the centre of the field. The question—why do effective medicines remain out of reach for much of the world?—drove research on pricing, patents, voluntary licensing, tiered pricing, and the TRIPS agreement's flexibilities. The concept of essential medicines, developed by the World Health Organization from 1977, provided a policy instrument: a list of medicines judged necessary for basic health care, used by many countries to guide procurement. Policy analysis in this vein studies regulation, reimbursement, intellectual property, and procurement as levers on access and affordability.
Health Technology Assessment and Evidence-Based Reimbursement
Health technology assessment, or HTA, is the systematic evaluation of a health technology's clinical, economic, and social consequences, used to inform coverage decisions5. Its institutional rise from the 1980s—through bodies such as the U.S. Office of Technology Assessment, and later agencies in Canada, the UK (NICE, established 1999), and across Europe—gave pharmacoeconomics and pharmacoepidemiology a direct route into policy. HTA synthesizes systematic reviews, economic models, and budget impact into a recommendation. It is where the field's measurement tools meet the state's purchasing power, and it has made the field's methods matter to patients far beyond academia.
The Present Field
Today social and administrative pharmacy is a mature, methodologically diverse field taught in pharmacy schools worldwide and published across journals of pharmacy practice, health economics, pharmacoepidemiology, and health policy. Its main approaches descend clearly from the history above: pharmacoepidemiological data analysis from population medicine and drug safety; pharmacoeconomic and HTA modelling from health economics; social-pharmacy qualitative and survey methods from sociology and psychology; and policy analysis of pricing, regulation, and access from law and political economy. The unifying question remains the one that gave the field its identity—how do medicines become, or fail to become, effective care?
Several questions remain open. How should value be priced when expensive new therapies, from gene therapies to oncology drugs, strain budgets and HTA methods built around the QALY? How can real-world data from electronic records and registries be made reliable enough to substitute for or supplement trials? How should deprescribing and medication safety be built into routine care rather than added on? And how can access be widened globally without undermining the innovation that produces new medicines? These are the live edges of a field that began by noticing that a drug on a shelf is not yet a medicine in a person.
References
- Pharmacy (Consultant pharmacy), Wikipedia
- Pharmaceutical care (History), Wikipedia
- Quality-adjusted life year (History), Wikipedia
- Pharmacoepidemiology, Wikipedia
- Health technology assessment, Wikipedia
The frameworks of Social And Administrative Pharmacy
Each framework is a way of working the field has used: when it held, and the question it answers.
- 1945-Present
Hospital Pharmacy Administration
How should a hospital pharmacy be organized and managed?
- 1950-Present
- 1970-Present
- 1977-Present
Pharmaceutical policy
Who decides what medicines are approved and paid for?
- 1980-Present
- 1980-Present
Pharmacoepidemiology
What happens when medicines are used by whole populations?
- 1985-Present
Health Technology Assessment
Should a health technology be adopted and paid for?
- 1985-Present
- 1990-Present
Medication Safety
How do medication errors happen and how can they be prevented?
- 1990-Present
Pharmaceutical Care
How can pharmacists take responsibility for drug therapy outcomes?
- 1995-Present
Access to Medicines
Why do effective medicines remain out of reach for many people?
- 2005-Present
How the ideas connect
Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.
Access to Medicines grew out of Pharmaceutical policy
Access to medicines grew out of pharmaceutical policy analysis when globalization and the HIV/AIDS crisis turned policy attention to pricing, patents, and licensing, extending the field's questions to global equity.
Patient adherence influenced by Pharmacy Administration
Pharmacy administration's interest in how prescriptions are actually filled and used fed into early adherence research, which applied administrative and survey methods to measure whether patients took prescribed medicines.
Social Pharmacy rival of Pharmacy Administration
Pharmacy administration and social pharmacy emerged in the same period as competing approaches to studying medicines in society, one economic and managerial, the other sociological and behavioural.
Pharmaceutical policy grew out of Pharmacy Administration
Pharmaceutical policy analysis grew out of pharmacy administration's concern with reimbursement, pricing, and regulation, extending those questions to national and international policy.
Pharmacoeconomics grew out of Pharmacy Administration
Pharmacoeconomics grew out of pharmacy administration's economic questions about drug costs, importing cost-effectiveness and cost-utility methods to compare medicines with alternatives.
Pharmaceutical Care influenced by Patient adherence
Adherence research's finding that patients adapt or abandon regimens fed into pharmaceutical care, which made the pharmacist accountable for identifying and resolving drug therapy problems including non-adherence.
Carried by Charles Hepler; Linda Strand.
Health Technology Assessment influenced by Pharmacoeconomics
Health technology assessment took up the cost-effectiveness and cost-utility methods developed in pharmacoeconomics and applied them to the evaluation of health technologies, including medicines.
Medication Safety influenced by Pharmacoepidemiology
Pharmacoepidemiology's methods for detecting adverse drug reactions in populations supplied the evidence base for medication safety research, which catalogues error types and designs system-level interventions.
Carried by Brian Strom.
Pharmaceutical Care influenced by Outcomes Research
Outcomes research's focus on measuring real-world results gave pharmaceutical care its research agenda: how to document pharmacist interventions and show that they improve patient outcomes.
Carried by Charles Hepler; Linda Strand.
Deprescribing influenced by Medication Safety
Medication safety research on prescribing cascades and drug-related harm in the elderly fed into deprescribing, which framed stopping a medicine as a clinical act to prevent harm.
Beyond the field
Where Social And Administrative Pharmacy's ideas came from in other fields, and what they led to there: the strongest 12 of 63 links.
Hospital Pharmacy Administration grew out of Hospital Pharmacy Practice in Pharmacy Practice
Hospital pharmacy administration emerged as the managerial and organizational branch of hospital pharmacy practice, formalized in US hospital pharmacy literature and the founding of ASHP's administrative section in the 1940s. The administrative framework took the institutional setting and dispensing workflow of hospital practice as its object of management.
Carried by American Society of Hospital Pharmacists.
Pharmacy Administration grew out of Hospital Pharmacy Practice in Pharmacy Practice
Pharmacy administration as an academic and professional field grew out of hospital pharmacy practice, whose institutional problems of staffing, purchasing and drug distribution were the first subjects of the new administrative literature and university courses in the 1950s.
Pharmacoeconomics grew out of Health Economics in Health Policy
Pharmacoeconomics grew directly out of health economics, applying its cost-benefit, cost-effectiveness and cost-utility methods to pharmaceutical products and services. The field's founding literature in the early 1980s explicitly framed itself as health economics applied to drugs.
Pharmacoeconomics influenced by Economic Evaluation and Cost-Effectiveness Analysis in Health Policy Evaluation
Pharmacoeconomics adopted economic evaluation and cost-effectiveness analysis as its core methods, transferring the techniques developed in health policy evaluation during the 1970s to the assessment of medicines.
Health Technology Assessment influenced by Economic Evaluation in Health Services Research
Health technology assessment adopted the methods of economic evaluation, especially cost-effectiveness and cost-utility analysis, as its central appraisal tools. The field's assessments are structured around these economic techniques.
Pharmaceutical Care grew out of Clinical Pharmacy in Pharmacy Practice
Pharmaceutical care developed out of clinical pharmacy as its refinement into a general philosophy of practice. The clinical pharmacy tradition supplied the patient-care orientation that pharmaceutical care codified.
Carried by Hepler and Strand, Opportunities and Responsibilities in Pharmaceutical Care (1990).
Pharmaceutical Care grew out of Clinical pharmacy in Pharmacy
Pharmaceutical care grew directly out of clinical pharmacy, extending its patient-oriented practice into an explicit philosophy of pharmacist responsibility for drug therapy outcomes. The 1990 Hepler and Strand formulation built on the clinical pharmacy movement.
Carried by Hepler and Strand, Opportunities and Responsibilities in Pharmaceutical Care (1990).
Pharmaceutical Care grew out of Clinical Pharmacy Movement in Clinical Pharmacy
Pharmaceutical care is the direct successor of the clinical pharmacy movement, taking its patient-oriented practice and making pharmacist accountability for outcomes its organising principle. The movement's leaders formulated pharmaceutical care.
Carried by Hepler and Strand, Opportunities and Responsibilities in Pharmaceutical Care (1990).
Pharmaceutical Care led to Medication Therapy Management in Pharmacy Practice
Medication therapy management was created in the 2003 Medicare Modernization Act as a formalised service model carrying out pharmaceutical care's goal of optimising drug therapy for individual patients.
Carried by Medicare Modernization Act (2003).
Hospital Pharmacy Administration influenced by Dispensing and Prescription-Fulfilment Model in Pharmacy Practice
Hospital pharmacy administration built its procedures for drug distribution, floor stock and prescription handling on the older dispensing and prescription-fulfilment model, adapting its workflow to the institutional ward setting. The dispensing model supplied the operational template that hospital administrators then reorganized and supervised.
Hospital Pharmacy Administration influenced Pharmacy Informatics and Automation in Pharmacy Practice
Hospital pharmacy administration supplied the inventory, distribution and workload-management problems that early pharmacy automation and information systems addressed. Unit-dose distribution and formulary management were among the first functions computerized.
Pharmacy Administration influenced Pharmacy Informatics and Automation in Pharmacy Practice
Pharmacy administration provided the management questions about workload, cost and workflow that pharmacy informatics and automation were developed to answer. The first pharmacy computer systems were justified and designed within pharmacy administration's concerns.

Social And Administrative Pharmacy is a planet in Nousfarer
Its city has a tower for each of these 13 frameworks. Land, walk in, and climb one concept at a time.
Land on Social And Administrative PharmacyRelated fields
Fields its ideas are linked to
- Pharmacy Practice 19 links
- Pharmacoepidemiology 10 links
- Clinical Pharmacy 7 links
- Pharmacology 5 links
- Pharmacy 5 links
- Pharmaceutical Economics 4 links
- Health Policy Evaluation 2 links
- Health Services Research 2 links
- Pharmacovigilance 2 links
- Health Policy 2 links
- Health Economics 1 link
- Health Technology Assessment 1 link
More in Pharmacy
See where Social And Administrative Pharmacy sits on the Map of Human Knowledge